Cargando…

Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model

BACKGROUND: Yeast products and psyllium husk may provide relief from clinical signs of colitis due to their ability to promote gut integrity, modulate gut microbiota, or positively affect immune responses, which have been demonstrated in several species. OBJECTIVE: The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ching-Yen, Lee, Anne H, Chiu, Karen K, Vieson, Miranda D, Steelman, Andrew J, Swanson, Kelly S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658636/
https://www.ncbi.nlm.nih.gov/pubmed/33215055
http://dx.doi.org/10.1093/cdn/nzaa159
_version_ 1783608715298996224
author Lin, Ching-Yen
Lee, Anne H
Chiu, Karen K
Vieson, Miranda D
Steelman, Andrew J
Swanson, Kelly S
author_facet Lin, Ching-Yen
Lee, Anne H
Chiu, Karen K
Vieson, Miranda D
Steelman, Andrew J
Swanson, Kelly S
author_sort Lin, Ching-Yen
collection PubMed
description BACKGROUND: Yeast products and psyllium husk may provide relief from clinical signs of colitis due to their ability to promote gut integrity, modulate gut microbiota, or positively affect immune responses, which have been demonstrated in several species. OBJECTIVE: The objective of this study was to investigate the effects of a Saccharomyces cerevisiae fermentation product (SCFP) and psyllium husk (PH) on cecal and fecal microbiota, colonic gene expression and histopathology, and mesenteric lymph node (MLN) immune cells in a dextran sulfate sodium (DSS)–induced colitis model. METHODS: Male C57BL/6J mice (n = 54) were assigned to a control, 5% SCFP, or 5% PH diet. After 2 wk of diet adaptation, mice were provided distilled water or 3% (wt:vol) DSS for 5 d ad libitum. Body weight, food and water intakes, and disease activity index (DAI) were recorded daily during the treatment period. Fresh fecal samples were collected before and during treatment for microbial analyses. After treatment, mice were killed, followed by tissue collection. Tissues were stored in proper solutions until further analyses. Data were analyzed using the Mixed Models procedure of SAS 9.4 (SAS Institute). RESULTS: Consumption of SCFP increased (P < 0.05) species richness of the gut microbiota and relative abundance of Butyricicoccus in fecal and cecal samples compared with control or PH mice. PH mice had greater (P < 0.05) gene expression of claudin (Cldn) 2, Cldn3, Cldn8, and occludin(Ocln) compared with control mice. DAI, MLN immune cell populations, colonic histopathology, and colonic gene expression were not affected (P > 0.05) by SCFP in DSS mice. DSS mice consuming PH had lower (P < 0.05) DAI compared with control or SCFP mice. CONCLUSIONS: Results suggest that, despite the modest changes it had on cecal and fecal microbiota, SCFP did not attenuate clinical signs associated with DSS-induced colitis in mice, while PH showed protective effects.
format Online
Article
Text
id pubmed-7658636
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76586362020-11-18 Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model Lin, Ching-Yen Lee, Anne H Chiu, Karen K Vieson, Miranda D Steelman, Andrew J Swanson, Kelly S Curr Dev Nutr ORIGINAL RESEARCH BACKGROUND: Yeast products and psyllium husk may provide relief from clinical signs of colitis due to their ability to promote gut integrity, modulate gut microbiota, or positively affect immune responses, which have been demonstrated in several species. OBJECTIVE: The objective of this study was to investigate the effects of a Saccharomyces cerevisiae fermentation product (SCFP) and psyllium husk (PH) on cecal and fecal microbiota, colonic gene expression and histopathology, and mesenteric lymph node (MLN) immune cells in a dextran sulfate sodium (DSS)–induced colitis model. METHODS: Male C57BL/6J mice (n = 54) were assigned to a control, 5% SCFP, or 5% PH diet. After 2 wk of diet adaptation, mice were provided distilled water or 3% (wt:vol) DSS for 5 d ad libitum. Body weight, food and water intakes, and disease activity index (DAI) were recorded daily during the treatment period. Fresh fecal samples were collected before and during treatment for microbial analyses. After treatment, mice were killed, followed by tissue collection. Tissues were stored in proper solutions until further analyses. Data were analyzed using the Mixed Models procedure of SAS 9.4 (SAS Institute). RESULTS: Consumption of SCFP increased (P < 0.05) species richness of the gut microbiota and relative abundance of Butyricicoccus in fecal and cecal samples compared with control or PH mice. PH mice had greater (P < 0.05) gene expression of claudin (Cldn) 2, Cldn3, Cldn8, and occludin(Ocln) compared with control mice. DAI, MLN immune cell populations, colonic histopathology, and colonic gene expression were not affected (P > 0.05) by SCFP in DSS mice. DSS mice consuming PH had lower (P < 0.05) DAI compared with control or SCFP mice. CONCLUSIONS: Results suggest that, despite the modest changes it had on cecal and fecal microbiota, SCFP did not attenuate clinical signs associated with DSS-induced colitis in mice, while PH showed protective effects. Oxford University Press 2020-10-15 /pmc/articles/PMC7658636/ /pubmed/33215055 http://dx.doi.org/10.1093/cdn/nzaa159 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle ORIGINAL RESEARCH
Lin, Ching-Yen
Lee, Anne H
Chiu, Karen K
Vieson, Miranda D
Steelman, Andrew J
Swanson, Kelly S
Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title_full Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title_fullStr Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title_full_unstemmed Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title_short Saccharomyces cerevisiae Fermentation Product Did Not Attenuate Clinical Signs, but Psyllium Husk Has Protective Effects in a Murine Dextran Sulfate Sodium–Induced Colitis Model
title_sort saccharomyces cerevisiae fermentation product did not attenuate clinical signs, but psyllium husk has protective effects in a murine dextran sulfate sodium–induced colitis model
topic ORIGINAL RESEARCH
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658636/
https://www.ncbi.nlm.nih.gov/pubmed/33215055
http://dx.doi.org/10.1093/cdn/nzaa159
work_keys_str_mv AT linchingyen saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel
AT leeanneh saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel
AT chiukarenk saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel
AT viesonmirandad saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel
AT steelmanandrewj saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel
AT swansonkellys saccharomycescerevisiaefermentationproductdidnotattenuateclinicalsignsbutpsylliumhuskhasprotectiveeffectsinamurinedextransulfatesodiuminducedcolitismodel